An exploratory study of metabolomics in endogenous and cannabis-use-associated psychotic-like experiences in adolescence
Open Access
- 7 November 2024
- journal article
- research article
- Published by Springer Nature in Translational Psychiatry
- Vol. 14 (1) , 1-9
Abstract
In adolescence, psychotic-like experiences (PLE) may indicate potential prodromal symptoms preceding the onset of psychosis. Metabolomic studies have shown promise in providing valuable insights into predicting psychosis with enhanced precision compared to conventional clinical features. This study investigated metabolomic alterations associated with PLE in 76 depressed adolescents aged 14–20 years. Serum concentrations of 92 metabolites were analyzed with liquid chromatography–mass spectrometry. PLE were assessed using the Youth Experiences and Health (YEAH) questionnaire. The associations between PLE symptom dimensions (delusions, paranoia, hallucinations, negative symptoms, thought disorder, and dissociation) and metabolite concentrations were analyzed in linear regression models adjusted for different covariates. The symptom dimensions consistently correlated with the metabolome in different models, except those adjusted for cannabis use. Specifically, the hallucination dimension was associated with 13 metabolites (acetoacetic acid, allantoin, asparagine, decanoylcarnitine, D-glucuronic acid, guanidinoacetic acid, hexanoylcarnitine, homogentisic acid, leucine, NAD+, octanoylcarnitine, trimethylamine-N-oxide, and valine) in the various linear models. However, when adjusting for cannabis use, eight metabolites were associated with hallucinations (adenine, AMP, cAMP, chenodeoxycholic acid, cholic acid, L-kynurenine, neopterin, and D-ribose-5-phosphate). The results suggest diverse mechanisms underlying PLE in adolescence; hallucinatory experiences may be linked to inflammatory functions, while cannabis use may engage an alternative metabolic pathway related to increased energy demand and ketogenesis in inducing PLE. The limited sample of individuals with depression restricts the generalizability of these findings. Future research should explore whether various experiences and related metabolomic changes jointly predict the onset of psychoses and related disorders.Keywords
All Related Versions
Funding Information
- Research Council of Finland (352509, 352509)
- Lastentautien Tutkimussäätiö (190162, 190162, 2020)
This publication has 61 references indexed in Scilit:
- An integrated pathological research for precise diagnosis of schizophrenia combining LC-MS/1H NMR metabolomics and transcriptomicsClinica Chimica Acta, 2022
- Dysregulated Lipid Metabolism Precedes Onset of PsychosisBiological Psychiatry, 2021
- Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in AdolescenceJAMA Psychiatry, 2021
- Three types of psychotic-like experiences in youth at clinical high risk for psychosisEuropean Archives of Psychiatry and Clinical Neuroscience, 2020
- Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and ChildrenBiological Psychiatry, 2019
- Profiling of lipidomics before and after antipsychotic treatment in first-episode psychosisEuropean Archives of Psychiatry and Clinical Neuroscience, 2019
- Rising stars: Modulation of brain functions by astroglial type‐1 cannabinoid receptorsGlia, 2014
- Oxidative stress and neopterin abnormalities in schizophrenia: A longitudinal studyJournal of Psychiatric Research, 2010
- The Pittsburgh sleep quality index: A new instrument for psychiatric practice and researchPsychiatry Research, 1989
- Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluationClinical Psychology Review, 1988